Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJLEN.L Regulatory News (JLEN)

  • There is currently no data for JLEN

Update research from QuotedData

31 Mar 2023 15:20

RNS Number : 0048V
JLEN Environmental Assets Group Ltd
31 March 2023
 

JLEN Environmental Assets Group - Update research from QuotedData

31st March 2023

Laying the foundations for NAV growth

In common with its peers, JLEN Environmental Assets (JLEN) experienced an eventful but fruitful 2022. Volatile power prices, rampant inflation, rising interest rates and new taxes buffeted the renewables sector but generally acted as a tailwind for net asset value (NAV) growth. Some of these issues will continue to affect the sector in 2023. We explore all of these from page 4 onwards.

JLEN's managers can have little influence on these big macroeconomic factors but they can, through their investment activity, lay the foundations for future NAV uplifts.

At the end of its last accounting year, JLEN had 6% of its portfolio in assets under construction or development, and a sizeable pipeline of new opportunities. As they reach maturity, these projects can act as an engine for capital growth.

Full Research:

https://quoteddata.com/research/jlen-environmental-assets-laying-foundations-nav-growth-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on JLEN Environmental Assets Group Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAJBMITMTBJBLJ
Date   Source Headline
23rd Mar 20217:00 amRNSAcquisition
8th Mar 202111:22 amRNSResult of EGM
3rd Mar 20217:00 amRNSAcquisition
24th Feb 20217:00 amRNSNotice of Capital Markets Day
16th Feb 202112:28 pmRNSUpdate research from QuotedData
16th Feb 20217:00 amRNSPublication of Shareholder Circular, Notice of EGM
15th Feb 202110:09 amRNSDirector Declaration
12th Feb 20217:00 amRNSNet Asset Value and Dividend Declaration
4th Feb 20217:00 amRNSAcquisition
4th Dec 20201:17 pmRNSAcquisition
26th Nov 20207:00 amRNSHalf-year Results, Dividend Declaration
27th Oct 20207:00 amRNSNotice of Results
18th Sep 20207:00 amRNSAcquisition
15th Sep 20206:00 pmRNSHolding(s) in Company
3rd Sep 20202:22 pmRNSResult of AGM and Directorate Change
18th Aug 20207:00 amRNSNet Asset Value and Dividend Declaration
7th Aug 20204:38 pmRNSDirector Declaration
30th Jun 20205:12 pmRNSNotice of AGM
11th Jun 20204:25 pmRNSDirectorate Change
11th Jun 20207:00 amRNSAnnual Financial Report
28th May 20207:00 amRNSNet Asset Value and Dividend
14th May 202011:16 amRNSUpdate research from QuotedData
7th May 20207:00 amRNSNotice of Results
2nd Apr 20207:00 amRNSAcquisition
1st Apr 20208:06 amRNSTotal Voting Rights
26th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20202:11 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSAppointment of Non-Executive Director
27th Feb 20207:00 amRNSResult of Placing
13th Feb 20209:33 amRNSHolding(s) in Company
11th Feb 20207:02 amRNSRestructuring of Investment Advisory Arrangements
11th Feb 20207:00 amRNSProposed Placing
29th Jan 20207:00 amRNSNet Asset Value and Dividend Declaration
28th Jan 20207:00 amRNSPartnership Commitment
13th Dec 20197:00 amRNSAcquisition
4th Dec 20195:44 pmRNSHolding(s) in Company
21st Nov 20197:00 amRNSHalf-year Results, Dividend Declaration
17th Oct 20197:00 amRNSNotice of Results
10th Sep 20197:45 amRNSUpdate research from QuotedData
29th Aug 20192:36 pmRNSHolding(s) in Company
29th Aug 20197:00 amRNSAcquisition
15th Aug 20197:00 amRNSNet Asset Value and Dividend Declaration
14th Aug 20194:22 pmRNSResult of AGM & Change of Company Name
19th Jul 20197:00 amRNSAcquisition
5th Jul 20195:05 pmRNSNotice of AGM
1st Jul 20192:51 pmRNSChange of Adviser
13th Jun 20197:00 amRNSAnnual Financial Report
5th Jun 20197:00 amRNSProposed Change of Investment Adviser
30th May 20197:00 amRNSNet Asset Value and Dividend Declaration
20th May 20197:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.